@article{ac430979ab10404d86f03ca1c4c4bdbe,
title = "Efficacy of type 2-targeted biologics in patients with asthma and bronchiectasis",
author = "Elizabeth Kudlaty and Patel, {Gayatri B.} and Michelle Prickett and Chen Yeh and Peters, {Anju T.}",
note = "Funding Information: Disclosures: Dr Peters is a consultant for Sanofi-Regeneron, AstraZeneca, and Optinose and receives research support from AstraZeneca and Optinose. The remaining authors have no conflicts of interest to report.Funding: This study receives funding from the Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine; Chronic Rhinosinusitis Integrative Studies Program (National Institutes of Health P01AI145818); National Institutes of Health T32AI083216; and Ernest Bazley Foundation.",
year = "2021",
doi = "10.1016/j.anai.2020.11.014",
language = "English (US)",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
}